Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with L
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q1 2024 | LECITHIN, SOYBEAN | ORAL | CAPSULE | 20.00 mg | Correction | ||
| Q1 2024 | LECITHIN, SOYBEAN | ORAL | POWDER, FOR SUSPENSION | 39mg | Correction | ||
| Q1 2024 | LECITHIN, SOYBEAN | ORAL | TABLET | 8mg | Correction | ||
| Q1 2024 | LECITHIN, SOYBEAN | ORAL | TABLET, EXTENDED RELEASE | 20mg | Correction | ||
| Q1 2024 | LECITHIN, SOYBEAN | ORAL | TABLET, FILM COATED | 0.33 mg | Correction | ||
| Q1 2024 | LECITHIN, SOYBEAN | RESPIRATORY (INHALATION) | AEROSOL, METERED | 0.10 %w/w | Correction | ||
| Q1 2024 | LECITHIN, SOYBEAN | VAGINAL | CREAM | 1.00 %w/w | Correction | ||
| Q1 2024 | LACTOSE MONOHYDRATE | ORAL | CAPSULE, EXTENDED RELEASE | 536.40 mg | MDE Replacement | ||
| Q2 2024 | LACTOSE MONOHYDRATE | ORAL | CAPSULE, EXTENDED RELEASE | 5364mg | MDE Replacement | ||
| Q1 2024 | LANOLIN | RECTAL | OINTMENT | 14.00 %w/w | MDE Replacement | ||
| Q2 2024 | LANOLIN | RECTAL | OINTMENT | 105mg | MDE Replacement | ||
| Q1 2024 | LAURYL LACTATE | TRANSDERMAL | FILM, EXTENDED RELEASE | 12.00 mg | MDE Replacement | ||
| Q2 2024 | LAURYL LACTATE | TRANSDERMAL | FILM, EXTENDED RELEASE | 12mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: March 15, 2024
Database Last Updated: April 29, 2024